Managing the Side Effects of Psychotropic Medications, Second Edition


Book Description

"This book has been divided into three main sections. Part I deals with global issues that bear on the assessment and formulation of possible adverse effects and with pertinent concepts related to basic pharmacology, physiology, and medical monitoring. The chapters in Part II present information organized by individual organ systems or specific medical circumstances rather than by drugs or drug classes. This approach seems to provide a logical and comprehensible format that allow readers to search out information as referenced by a particular side effect (and its varied potential causes) and to locate a discussion of practical management strategies. Part III focuses on summary recommendations covering all the material presented in the book and is followed by helpful appendixes on self-assessment questions and resources for practitioners. The book is meant to serve as a ready reference that simultaneously provides scientific and scholarly discussion of available treatment options and presents their scientific rationales."--page xx.




Psychotropic Drug Handbook


Book Description




Clinical Handbook of Psychotropic Drugs


Book Description

Includes bibliography, glossary, and an extensive index which cross-references generic and trade names. New editions are available on a subscription basis.




Psychotropic Drug Handbook


Book Description

This succinct handbook provides students and practitioners with clinically relevant psychotropic drug information. The Eighth Edition is designed as a reference text that also teaches by delivering informative narrative text under standard headlines with references. Its focus goes beyond drug information to cover pharmacotherapy applications. The book provides detailed, well-referenced, evidence-based information on a wide range of psychotropic drugs, including mood stabilizers, antidepressants, and antianxiety agents. This edition has new chapters on pediatric and geriatric psychopharmacotherapy; new content on antipsychotics, hypnotics, medications used in treating alcoholism and substance dependence, and electroconvulsive therapy; and new algorithms, appendices, and tables.




Managing the Side Effects of Psychotropic Medications


Book Description

Information about new psychotropic drugs, a summary of advances in knowledge about identifiable risk factors for adverse effects, and updated recommendations on viable "antidote" management strategies -- including novel pharmacotherapies for tardive dyskinesia and newer agents for weight loss -- are among the features of this new, second edition of Managing the Side Effects of Psychotropic Medications. Where other psychopharmacology textbooks -- and, indeed, most internships and residencies in psychiatry -- lack a solid basis in primary care medicine, this guide bridges that educational gap, offering a thorough examination of all the effects of taking a psychotropic drug as well practical clinical advice on how to manage complications that arise. The book is divided into three parts: The first deals with global issues that affect the assessment and formulation of possible adverse effects, as well as with pertinent concepts related to basic pharmacology, physiology, and medical monitoring. The second part presents information organized by individual organ systems or specific medical circumstances. The final part focuses on summary recommendations covering all the material presented in the book and is followed by helpful appendixes and self-assessment questions and resources for practitioners. This new edition includes: Updated summaries about what psychiatrists should know regarding drug-drug interactions, iatrogenic cardiac arrhythmias, drug pressor effects and orthostatic hypotension, and drug rashes; as well as updated discussions on avoiding lithium nephrotoxicity, handling adverse effect emergencies, and understanding new FDA classifications about drug safety during pregnancy An expanded discussion on the strengths and limitations of pharmacogenetic testing to predict adverse drug effects, as well as information about new treatments for sexual dysfunction, sleep disturbances, cognitive complaints, and other maladies Revised summary tables to aid rapid assessment and management An expanded section on supplemental resources An updated and expanded self-assessment section with more key questions Busy clinicians will find in Managing the Side Effects of Psychotropic Medications an accessible reference that provides both scientific and scholarly discussion of the consequences of drug therapies they may prescribe (or avoid), the range of available strategies to effectively manage adverse effects, and the scientific and practical implications of their treatment decisions.




Practical Management of the Side Effects of Psychotropic Drugs


Book Description

This practical reference provides a clinically oriented management guide to the secondary results of all major classes of psychotropic medications used in North America. Practical Management of the Side Effects of Psychotropic Drugs describes the symptoms, frequency, and treatment options to certain drug reactions addresses general issues of side effect management, such as mechanisms of action, differential diagnosis, patient education, quality of life, and potential legal ramifications explores which compounds are tolerated best in patients with dysthymia, post-traumatic stress disorder, and certain personality disorders covers agents applied in the control of alcoholism and drug abuse discusses dealing with special populations, including the elderly, minorities, and medically ill patients and more! With over 900 references and tables, Practical Management of the Side Effects of Psychotropic Drugs is ideally suited for clinical psychiatrists, primary care physicians, internists, neurologists, psychotherapists, pharmacologists, clinical psychopharmacologists, neuropsychopharmacologists, pharmaceutical and behavioral scientists, and graduate and medical school students in these disciplines.




Psychotropic Agents


Book Description

The volumes on "psychotropic substances" in the Handbook of Experimental Phar macology series clearly show that the classical concept of this discipline has become too narrow in recent years. For instance, what substances are psychotropic is determined not by the criteria of the animal trial, i.e. by experimental pharmacology, but by their action on the psy che, which in the final analysis is only accessible to us in man. Psychotropic substances force experimental pharmacology (and thus also this Handbook) outside its tradition allimits, which have essentially depended on animal studies. The antipsychotics and antidepressants were not discovered in animal ex periments, but by chance (or more precisely, by clinical empiricism). Experienced psy chiatrists trained in the observation of patients recognised the efficacy of drugs, the beneficial effect of which nobody had dreamed of before: DELAY and DENICKER in the case of chlorpormazine, KLINE in the case of the monoamine oxidase inhibitors and KUHN in the case of imipramine. It was only after these discoveries that the pharma cologists developed experimental models of the psychoses in animal experiments. However, even today we still do not know with certainty which of the effects shown in animals is relevant for the clinical effect despite the vast abundance of individual investigations. For many years, this uncertainty led to the testing of antipsychotics (e.g. of the neuroleptic type) in models which actually produced the undesired effects.




Psychotropic Drugs


Book Description

The authors provide thorough coverage of current psychotropic medications and pharmacologic practices used in nursing care. It examines psychotropic drug use, drugs used in treatment of medical disorders, drug issues related to psychopharmacology, and developmental issues related to psychotropic drugs. More than 90 drugs are profiled.




Psychotropic Drugs and Medical Conditions


Book Description

Pharmacotherapy is the most commonly used treatment method for psychiatric disorders. Many patients experience medical diseases concurrent with psychiatric disorders. In addition, some patients suffer from medical problems such as metabolic complications, neutropenia and electrolyte imbalance due to the use of psychopharmacological treatments. Therefore, current medical conditions and the medical history of patients with psychiatric disorders are important factors that can affect the choice of psychotropic drugs in the treatment of psychiatric disorders. Recently, there has been growing interest in the use of psychotropic drugs in patients with general medical conditions. This book summarises recent advances regarding reciprocal effects between the use of psychotropic drugs and general medical conditions.




Anatomy of an Epidemic


Book Description

Updated with bonus material, including a new foreword and afterword with new research, this New York Times bestseller is essential reading for a time when mental health is constantly in the news. In this astonishing and startling book, award-winning science and history writer Robert Whitaker investigates a medical mystery: Why has the number of disabled mentally ill in the United States tripled over the past two decades? Interwoven with Whitaker’s groundbreaking analysis of the merits of psychiatric medications are the personal stories of children and adults swept up in this epidemic. As Anatomy of an Epidemic reveals, other societies have begun to alter their use of psychiatric medications and are now reporting much improved outcomes . . . so why can’t such change happen here in the United States? Why have the results from these long-term studies—all of which point to the same startling conclusion—been kept from the public? Our nation has been hit by an epidemic of disabling mental illness, and yet, as Anatomy of an Epidemic reveals, the medical blueprints for curbing that epidemic have already been drawn up. Praise for Anatomy of an Epidemic “The timing of Robert Whitaker’s Anatomy of an Epidemic, a comprehensive and highly readable history of psychiatry in the United States, couldn’t be better.”—Salon “Anatomy of an Epidemic offers some answers, charting controversial ground with mystery-novel pacing.”—TIME “Lucid, pointed and important, Anatomy of an Epidemic should be required reading for anyone considering extended use of psychiatric medicine. Whitaker is at the height of his powers.” —Greg Critser, author of Generation Rx